[1]
W. Shalata, “Carpal Tunnel Syndrome as an Unusual Immune Checkpoint Inhibitor Adverse Effect: A Case Series and Review of the Literature”, ijirms, vol. 5, no. 11, pp. 550–553, Nov. 2020.